Understanding racial differences in recovery after critical illness
Examining Racial Disparities in Predictive Modeling Among Survivors of Critical Illness
This study is looking at how differences in race might impact the recovery of people who have survived serious illnesses, with the goal of making sure everyone gets the best care possible after leaving the hospital.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10901179 on NIH RePORTER |
What this research studies
This research investigates how racial disparities affect the recovery of patients who have survived critical illnesses. It focuses on identifying biases in predictive tools that assess the risk of complications and readmissions among these patients. By analyzing data from various healthcare systems, the research aims to improve post-acute care interventions and outcomes for survivors. The study will specifically look at mortality rates, readmission rates, and the number of days patients are free from hospital care within 90 days of their critical illness.
Who could benefit from this research
Good fit: Ideal candidates for this research are survivors of critical illness, particularly those from racially diverse backgrounds who may face disparities in healthcare access and outcomes.
Not a fit: Patients who have not experienced critical illness or those outside the targeted racial and ethnic groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more equitable healthcare interventions for survivors of critical illness, ultimately improving recovery outcomes for racially diverse patient populations.
How similar studies have performed: Previous research has shown success in addressing healthcare disparities and improving outcomes for diverse populations, indicating that this approach has potential for meaningful impact.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Naiditch, Hiam — University of Pittsburgh at Pittsburgh
- Study coordinator: Naiditch, Hiam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.